Abstract
Abstract
Background
Since cancer is one of the most prevalent diseases in the world, further studies are needed to identify the effective therapeutic modalities. The second deadliest and third most common cancer is colorectal cancer (CRC). Papaya (Carica papaya Linn) seeds offer anti-cancer properties that can cure various types of cancer, such as liver and prostate cancer.
Methods
The study aimed to evaluate the anti-cancer activity of Carica papaya seed extract on colorectal cancer cell lines (Caco-2) and used techniques to assess the anti-cancer potential. The effectiveness of SE on cell proliferation and the viability of HTB-37 Caco-2 and C-166 cells were assessed using the MTT test. Real-time RT-PCR was used to measure gene expression levels and evaluate the activity of genes involved in apoptosis, including caspase-3, p53, Cycs, and Bcl-2. Finally, flow cytometry was used to analyze apoptosis induction by detecting changes in cell morphology and DNA content.
Results
The study showed that the MTT reduction assay was dependent on cancer cell type and concentration of SE compared to the control cells and C-166, with a mean IC50 value of 9.734 ug/ml. The cytotoxicity was accompanied by some morphological alterations in the colorectal cancer cell line (Caco-2). The expression of the genes for p53, Cycs, and caspase-3 was substantially up-regulated, while Bcl-2 was dramatically down-regulated compared to control cells. The cell cycle arrested at the G2-M phase and the presence of early and late apoptotic characteristics post-treatment increased the apoptotic profile.
Conclusion
It concluded that papaya seeds aqueous extract could act as a novel therapeutic option for colorectal cancer (CRC).
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference37 articles.
1. Adel A, Elnaggar MS, Albohy A, Elrashedy AA, Mostafa A, Kutkat O, et al. Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling. RSC Adv. 2022;12:32844–52.
2. Gnanamangai BM, Ramachandran G, Maruthupandy M, Priya VM, Karthikeyan G, Mothana RA, et al. Bioactive compounds coated 2D scaffold from seeds of Carica papaya for bacterial and parasitic skin infections. Physiol Mol Plant Pathol. 2022;117:101778.
3. Koul B, Pudhuvai B, Sharma C, Kumar A, Sharma V, Yadav D, et al. Carica papaya L.: a tropical fruit with benefits beyond the Tropics. Diversity. 2022;14:683.
4. Saha S, Giri TK. Breaking the barrier of cancer through papaya extract and their formulation. Anti-Cancer Agents Med Chem (Formerly Curr Med Chem Agents). 2019;19:1577–87.
5. Kong YR, Jong YX, Balakrishnan M, Bok ZK, Weng JKK, Tay KC, et al. Beneficial role of Carica papaya extracts and phytochemicals on oxidative stress and related diseases: a mini review. Biology (Basel). 2021;10:287.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献